-
Mashup Score: 8Targeting the HIF2–VEGF axis in renal cell carcinoma - 4 year(s) ago
Anticancer therapies that target the HIF oxygen-sensing pathways are moving into the clinic, in particular in kidney cancer.
Source: Nature MedicineCategories: Hem/Oncs, Latest HeadlinesTweet
1/Our Perspective @NatureMedicine with #BillKaelin @KaelinLab to coincide with the 1-year anniversary of the 2019 @nobelprize on oxygen sensing/HIF. Link: https://t.co/DjNUkgqZqy https://t.co/9815kPbYSr